Skip to content
Sustainable aviation fuel (SAF) production in the United States is expected to increase dramatically, from around 2,000 barrels per day (b/d) to nearly 30,000, […]
Daily SAF production set to jump from 2,000-30,000 barrels in 2024, U.S. EIA says Read More »
The heads of the three largest pharmacy benefit managers (PBMs) were grilled on July 23 by the House Oversight and Accountability Committee, whose new
House Oversight Committee grills PBM executives over ‘despicable’ practices Read More »
Farmers, biotech firms, the federal government, and other stakeholders are cooperating closely to tackle the emerging challenge of protecting cattle against avian flu, said
Public-private partnerships drive response to avian flu in cattle, panel says Read More »
Antimicrobial resistance (AMR) presents a clear threat to human health and healthcare systems. And in the post-COVID era, the threat and calls to address
AMR infections increased 20% during COVID-19 – and continue to pose a threat Read More »
July has turned out to be a good month for the fight against Alzheimer’s, with the approval of a new plaque-reducing drug and a
Kisunla approval and proposed CMS change signal progress against Alzheimer’s Read More »
2001 was the dawn of the modern era of biosecurity in the United States. Following the 9/11 attacks and deadly anthrax letters, the nation
The House Ways and Means Committee learned how lawmakers can enable progress in biotech from a Biotechnology Innovation Organization (BIO) Board member and the
BIO Board member and head of BioUtah testify at House field hearing Read More »
The Federal Trade Commission (FTC) released an interim report on July 9 criticizing the negative impact pharmacy benefit managers (PBMs) have on prescription drug
FTC releases interim report criticizing PBMs Read More »
A few topics keep popping up in discussions about the future of U.S. healthcare over the past couple of years. The need to pass
3 key priorities shaping the future of U.S. healthcare and biotech Read More »
A bill to reauthorize a program that encourages the development of pediatric rare disease treatments was introduced in the Senate on June 20. Bill
Pediatric Priority Review Voucher reauthorization introduced in Senate Read More »
